Loading...
•
Mar 31, 2021
HCA Q1 2021 Earnings Report
HCA Healthcare's financial performance for Q1 2021 was reported, showing increased revenues and net income compared to the same period last year, along with revised full-year guidance.
Key Takeaways
HCA Healthcare reported strong first-quarter results with revenues of $13.977 billion and net income of $1.423 billion, or $4.14 per diluted share. The company also revised its 2021 full-year guidance, reflecting confidence in its operating performance.
Revenues totaled $13.977 billion, an increase from $12.861 billion in Q1 2020.
Net income attributable to HCA Healthcare, Inc. was $1.423 billion, or $4.14 per diluted share, compared to $581 million, or $1.69 per diluted share in Q1 2020.
Adjusted EBITDA totaled $3.052 billion, compared to $2.200 billion in the first quarter of 2020.
Cash flows from operating activities totaled $1.988 billion, compared to $1.375 billion in the first quarter of 2020.
HCA
HCA
Forward Guidance
The 2021 guidance ranges for the year have been revised from our fourth quarter release and are as follows:
Positive Outlook
- Revenues $54.0 to $55.5 billion
- Adjusted EBITDA $10.85 to $11.35 billion
- EPS (diluted) $13.30 to $14.30 per diluted share
- Capital Expenditures Approximately $3.7 billion
Challenges Ahead
- The Company’s 2021 guidance contains a number of assumptions, including, among others, the Company’s current expectations regarding the impact of the COVID-19 pandemic and related government legislation
- excludes the impact of items such as, but not limited to, gains or losses on sales of facilities, losses on retirement of debt, legal claims costs and impairment of long-lived assets.